Literature DB >> 7216611

Ribonuclease inhibitor from bovine brain.

L E Burton, P Blackburn, S Moore.   

Abstract

A ribonuclease inhibitor from bovine brain has been purified 27 000-fold by affinity chromatography on Sepharose-RNase A with an overall yield of 46% (ca. 0.4 mg/kg tissue). The purified inhibitor gives a single band by SDS-gel electrophoresis. By gel filtration the molecular weight is ca. 50 000; the molecular weight of the complex with bovine pancreatic RNase A is ca. 62 000, indicative of 1:1 binding on a molar basis. The inhibition of the action of RNase A on yeast RNA by the inhibitor is noncompetitive with a Ki of 7 x 10(-10) M. The protein is very similar in its properties, including amino acid composition, to the inhibitor previously isolated from human placenta. The amount of inhibitor per g of protein in bovine brain is about one-seventh of the value for human placenta. No difference was found in the distribution of inhibitor between white and gray matter; one-tenth of the inhibitor present is bound to a brain ribonuclease which is released in active form after reaction with p-hydroxymercuribenzoate. Essentially no free neutral ribonuclease activity could be detected in brain homogenates in the absence of p-hydroxymercuribenzoate.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7216611     DOI: 10.1111/j.1399-3011.1980.tb02959.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  11 in total

Review 1.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

2.  Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain.

Authors:  M P Sasso; A Carsana; E Confalone; C Cosi; S Sorrentino; M Viola; M Palmieri; E Russo; A Furia
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

3.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

4.  Ribonuclease activities in rat sympathetic ganglia: evidence for the presence of an endogenous inhibitor of alkaline ribonuclease.

Authors:  D J Bates; R T Good; L Austin
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

5.  Comparison of brain ribonucleases of rabbit, guinea pig, rat, mouse and gerbil.

Authors:  B Schulz-Harder; D Graf von Keyserlingk
Journal:  Histochemistry       Date:  1988

6.  Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

Authors:  J M Fominaya; J M García-Segura; M Ferreras; J G Gavilanes
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

7.  Specific RNase isoenzymes in the human central nervous system.

Authors:  B Allinquant; C Musenger; J Reboul; J J Hauw; E Schuller
Journal:  Neurochem Res       Date:  1987-12       Impact factor: 3.996

8.  The activity of neutral ribonucleases in nuclei of rat sympathetic ganglia and effects of nerve injury.

Authors:  D J Bates; G M Day; L Austin
Journal:  Neurochem Res       Date:  1987-06       Impact factor: 3.996

9.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

10.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.

Authors:  R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.